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Paraneoplastic pemphigus has been associated with both
malignancies and multicentric Castleman’s disease; the
latter is a rare angiolymphoproliferative disorder that has
also been linked with human herpesvirus 8 (HHV8)
infection. Other diseases definitively associated with
HHV8 include Kaposi’s sarcoma and primary effusion
lymphoma. In a search for additional HHV8-associated
diseases, patients with paraneoplastic pemphigus, as well
as patients with pemphigus vulgaris and pemphigus folia-
ceus, were studied. Using an immunofluorescence assay
able to specifically detect antibodies directed against
lytically induced HHV8 antigens, HHV8 antibodies were
not detected in sera from 24 patients with paraneoplastic
pemphigus (including 10 with concomitant Castleman’s
disease) nor from 19 patients with pemphigus vulgaris.
Sera from patients with Kaposi’s sarcoma and from
Chang and Moore first described human herpesvirus 8(HHV8), also known as Kaposi’s sarcoma (KS)-associ-ated herpesvirus, in 1994 (Chang et al, 1994). Sincethat discovery, numerous DNA and serologic studieshave documented HHV8 in all clinical types of KS
(i.e., classic, epidemic, endemic, iatrogenic) and in all tissues with
histologic evidence of KS (for recent review, see Blauvelt, 1998). In
addition, HHV8 has been associated with all cases of primary effusion
lymphoma (Cesarman et al, 1995) and with many cases of multicentric
Castleman’s disease (Soulier et al, 1995). Castleman’s disease is a rare
angiolymphoproliferative disease that can occur in patients infected
with human immunodeficiency virus (HIV) (Herrada et al, 1998). In
HIV-infected individuals, Castleman’s disease is nearly always associated
with HHV8 infection (.90% of cases), whereas Castleman’s disease in
HIV-seronegative individuals is associated with HHV8 in µ40% of
cases (Soulier et al, 1995; Grandadam et al, 1997; Parravicini et al,
1997a). Interestingly, Castleman’s disease can also occur in patients
with paraneoplastic pemphigus (PNP) (Anhalt, 1997; Jansen et al, 1995;
Lemon et al, 1997), a rare autoimmune mucocutaneous blistering
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healthy U.S. blood donors were positive (25 of 26) and
negative (none of 20), respectively. In addition, HHV8
DNA was not found in frozen lesional skin of five patients
with pemphigus vulgaris and five patients with pemphigus
foliaceus by nested polymerase chain reaction (lower
limit of detection J 10 copies viral DNA per mg total
cellular DNA). Finally, tissue sections of lesional skin
from 10 patients with pemphigus vulgaris were negative
for HHV8 by in situ hybridization, using probes able to
detect both latently and lytically expressed HHV8 genes
in Kaposi’s sarcoma tissue. In summary, no evidence of
HHV8 infection was found in all types of pemphigus
using a variety of methods. These findings do not support
a general role for HHV8 in skin diseases associated
with immunosuppression. Key words: in situ hybridization/
Kaposi’s sarcoma/polymerase chain reaction/serology. J Invest
Dermatol 111:781–783, 1998
disease (Anhalt et al, 1990; Anhalt, 1997). Because of this association,
patients with PNP (many of whom had concomitant Castleman’s
disease) were examined for evidence of HHV8 infection in this study.
In addition to KS, primary effusion lymphoma, and Castleman’s
disease, several other conditions have been reported to be associated
with HHV8. Diseases in this group include angiosarcoma (McDonagh
et al, 1996), angiolymphoid hyperplasia with eosinophilia (Gyulai et al,
1996), nonmelanoma skin cancers in immunosuppressed individuals
(Rady et al, 1995), sarcoidosis (DiAlberti et al, 1997), multiple myeloma
(Rettig et al, 1997), pemphigus vulgaris (PV), and pemphigus foliaceus
(PF) (Memar et al, 1997a, b). Most of these associations, however,
have either not been confirmed or have been disproved by subsequent
more carefully performed studies (Chang et al, 1994; Adams et al, 1995;
Boshoff et al, 1995, 1996; Dictor et al, 1996; Jin et al, 1996; Lin et al,
1996; Uthman et al, 1996; Cathomas et al, 1997; Cottoni and Uccini,
1997; Dupin et al, 1997; Lebbe et al, 1997a, b; MacKenzie et al, 1997;
Marcelin et al, 1997; Masood et al, 1997; Parravicini et al, 1997b;
Whitby et al, 1997; Moore, 1998; Regamey et al, 1998; Tarte et al,
1998). For patients with PV and PF, there have been no subsequent
reports confirming or refuting possible links with HHV8 as reported
initially by Memar et al (1997a, b). Thus, in addition to PNP patients,
patients with PV and PF were also examined for evidence of HHV8
infection in this study. Importantly, a combination of serologic assays,
in situ hybridization, and sensitive polymerase chain reaction (PCR)
assays were employed for this investigation.
MATERIALS AND METHODS
Patients PNP sera and frozen pemphigus tissue for PCR assays were obtained
from the Dermatology Department at Johns Hopkins University. PNP patients
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Figure 1. No evidence of HHV8-specific antibodies in sera from patients
with PNP. Sera from patients with PNP (A) or KS (B) were incubated at a
dilution of 1:20 with phorbol ester-stimulated HHV81 primary effusion
lymphoma cells. Negative (C) and positive (D) controls included in the
immunofluorescence kits were run each day that patient sera were tested. Primary
antibody labeling was detected using fluorescein isothiocyanate-conjugated anti-
human antibody and immunofluorescence microscopy. Gray cells indicate no
HHV8 antibody binding, whereas white cells (µ30% in positive controls and
KS sera) indicate HHV8 antibody binding. All sera were evaluated by an
investigator blinded with respect to the source of the sera. The data shown are
representative of numerous experiments (summarized in Table I).
Table I. Summary of results showing no evidence of HHV8
infection in all types of pemphigus
HHV8 mRNA
HHV8 antibodies HHV8 DNA (by in situ
Patients (by seroassay) (by nested PCR) hybridization)
PNP 0/24 – a – a
PV 0/19 0/5 0/10
PF –a 0/5 – a
KS 25/26 –b – b
Healthy volunteers 0/20 – a – a
aNot tested.
bTested on numerous occasions (.20) and always positive.
Figure 2. No evidence of HHV8 DNA in lesional skin of patients with
PF or PV by nested PCR. DNA was extracted from frozen lesional skin of
patients with KS, PF, or PV and examined for HHV8-specific DNA using a
sensitive nested PCR assay (see Materials and Methods). β-globin-specific DNA
was readily detected by non-nested and nested PCR in all samples tested (as a
test of the quality of DNA and PCR reagents), whereas HHV8-specific DNA
was only observed in KS lesions and BCBL-1 cells. The data shown are
representative of numerous experiments (summarized in Table I).
had severe mucocutaneous blistering disease and all had characteristic circulating
autoantibodies directed against 250, 230, 210, and 190 kDa keratinocyte proteins
by western blot (Anhalt et al, 1990). Ten PNP patients had associated Castleman’s
disease. Other disease associations included sarcoma (specifically not KS,
four patients), non-Hodgkin’s lymphoma (specifically not primary effusion
lymphoma, four patients), chronic lymphocytic leukemia (four patients), and
myofibroblastic tumor (one patient); one PNP patient had no documented
concomitant disease but the patient died with generalized lymphadenopathy
and hepatosplenomegaly. Diffuse Castleman’s was suspected but not proven at
time of death. Sera from healthy US blood donors and from well characterized
Figure 3. No evidence of HHV8-specific mRNA expression in lesional
skin from patients with PV by in situ hybridization. Sections of unstained
lesional skin from patients with PV (A) or KS (B) were incubated with a
riboprobe (T0.7) able to detect latently infected HHV81 cells (see Materials and
Methods). No HHV8-specific signals were observed in PV lesions, whereas the
majority of tumor spindle cells in KS lesions were labeled with this probe (black
dots). The data shown are representative of numerous experiments (summarized
in Table I).
patients with PV and PF were obtained from Kim Yancey (Dermatology
Branch, National Cancer Institute) and John Stanley (Department of Dermato-
logy, University of Pennsylvania). Tissues used for in situ hybridization were
obtained from archival specimens in the Pathology Department at University
of California, San Francisco. Sera and lesional biopsies were obtained from KS
patients (following informed consent) enrolled in studies approved by the
Institutional Review Board at the National Cancer Institute.
Serologic assay A commercially available immunofluorescence assay kit
(Advanced Biotechnologies, Columbia, MD) was used for all HHV8 serologic
studies according to manufacturer’s instructions (Masood et al, 1997). As a
source of viral antigens, this kit uses phorbol ester-stimulated HHV8-infected
cells derived from a patient with primary effusion lymphoma (Said et al, 1996),
i.e., it detects antibodies directed against lytically expressed HHV8 antigens.
Sera were tested at either 1:20 or 1:40 final dilution. All assays were performed
by one investigator (S.C.), using samples from healthy individuals and patients
with pemphigus or KS in random order. Using an immunofluorescence
microscope, coded slides were then examined and scored by a second investigator
(A.B.), without knowledge of the serum source.
Nested PCR Nested PCR was performed as previously described in detail
(Blauvelt et al, 1997). Briefly, DNA was extracted from frozen lesional skin
obtained from five patients with PV and five patients with PF using a
commercially available kit (Qiagen, Valencia, CA), according to manufacturer’s
instructions. DNA was quantitated by spectrophotometry and 1 µg of total
DNA was used as a template for outer PCR reactions (35 cycles), whereas 2%
of outer PCR reaction products were used as templates for inner PCR reactions
(35 cycles). DNA isolated from KS tissue and from the HHV81 cell line
BCBL-1 were used as positive PCR controls. Negative control reactions
contained all PCR reagents without DNA template. This assay is able to detect
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as little as 10 copies of HHV8 DNA per µg of total cellular DNA (Blauvelt
et al, 1997).
In situ hybridization In situ hybridization was performed as previously
described (Orenstein et al, 1997). Briefly, deparaffinized tissue sections from 10
formalin-fixed specimens of lesional PV skin were incubated with either a
digoxigenin-labeled T0.7 riboprobe (able to detect latently expressed HHV8
ORF K12 mRNA) or a digoxigenin-labeled T1.1 riboprobe (able to detect
lytically expressed HHV8 ORF K7 mRNA). Visualization of probe was carried
out with alkaline phosphatase-labeled anti-digoxigenin antibody and nitro blue
tetrazolium chloride/5-bromo-4-chloro-3-indoyl phosphate substrate (Boehr-
inger, Mannheim, Germany). Separate PV sections were stained for ALU
repetitive DNA sequences to evaluate nucleic acid integrity. KS tissue and
cytospins of BCBL-1 cells (HHV81 primary effusion lymphoma cells, NIH AIDS
Research & Reagent Program, Rockville, MD) were used as positive controls.
RESULTS AND DISCUSSION
Given that Castleman’s disease can be associated with both HHV8
infection (Soulier et al, 1995; Grandadam et al, 1997; Parravicini et al,
1997a) and PNP (Anhalt, 1997; Jansen et al, 1995; Lemon et al, 1997),
PNP patients were studied for evidence of HHV8 infection. Sera from
24 PNP patients, including 10 with concomitant Castleman’s disease,
did not demonstrate HHV8-specific antibodies (Fig 1, Table I). By
contrast, antibodies directed against HHV8 lytic antigens could readily
and reliably be detected in sera obtained from KS patients (25 of 26)
(Fig 1, Table I). Sera from 20 healthy US blood donors were HHV8-
nonreactive using this assay (Table I). This study is the first to examine
patients with PNP for HHV8 infection, and the results suggest that
HHV8 plays no role in the pathogenesis of this paraneoplastic disease.
Furthermore, no evidence of HHV8 infection in patients with other
forms of pemphigus was found. Specifically, PV patients demonstrated
no HHV8-specific antibodies in sera (Table I), no HHV8 DNA was
detected in lesional skin of PV or PF patients by nested PCR (Fig 2,
Table I), and HHV8 mRNA expressed by either latently or lytically
infected cells was not detected in lesional skin of PV patients by in situ
hybridization (Fig 3, Table I). Positive and negative controls gave
expected results for each of these assays (Figs 1–3, Table I). Also, PV
tissue used for in situ hybridization demonstrated clear ALU repetitive
DNA signals, indicating that nucleic acid integrity was intact in the
tested specimens (not shown). In short, the results of earlier studies
reporting HHV8 within skin of PV and PF patients could not be
confirmed (Memar et al, 1997a, b). These earlier studies may have
demonstrated false positive results because of PCR contamination, as
has occurred with other purported HHV8-associated diseases (Moore,
1998). To avoid potential contamination problems that are possible
with PCR, future investigations of HHV8 disease associations should
ideally include additional assays to detect virus, such as in situ hybridiza-
tion, serologic assays, or electron microscopy.
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